We’ve never been closer to nuclear catastrophe—who gains by ignoring it?
Antiwar and environmental activist Dr. Helen Caldicott warns that policymakers who understate the danger of nuclear weapons don’t have the public’s best interest at heart.
Replacing the capitalist dream of AI-driven profits
When asked to share alternatives to capitalism, ChatGPT offered many options, none of which rely on the fantasy that money hoarding at the top can eventually benefit the rest of us.
Donald Trump Has Some Explaining to Do
Are we going to find deep ties to Russia in those long-awaited tax returns?
What? A former prosecutor and attorney general running against a repeat convicted criminal?
Kamala Harris is making his felony conviction and his sexual assaults one of the central points of her strategy.
Trump’s nuclear orders revive a failed industry at the expense of public safety and...
Executive orders to quadruple U.S. nuclear capacity ignore cost overruns, radiation risks, and a global shift toward cheaper, safer renewables—all while gutting the agency meant to protect the public
Pocahontas is an inspiration, not a racial slur
If Trump were a reader of history, he might know that calling someone “Pocahontas” is actually a compliment, not an insult.
On Medicare and Medicaid’s 55th birthday, let’s expand benefits—not cut them
That includes improving Medicare and Medicaid, and expanding them to cover everyone in America.
Exxon’s Weapons of Mass Confusion on Climate Change
The real power, and our great hope, is in the People's rebellion: marches, civil disobedience, trainings, teach-ins and other actions to pressure leaders to put people and the planet over corporate profiteering.
How could the U.S. help to bring peace to Ukraine?
Policy decisions by the United States will have a critical impact on whether there will soon be peace in Ukraine, or only a much longer and bloodier war.
The 2024 election could be Big Pharma’s reckoning
It’s clear at this point that the 2024 election could very well hinge on which party can capture the populist mantle on Big Pharma.